Olmesartan Medoxomil 20/10 mg

Adult dose

The recommended initial dose of olmesartan medoxomil is 10 mg once daily, regardless of meals. If blood pressure is not adequately controlled, it can be increased to 20 mg once daily, with a maximum dose of 40 mg per day. The initial dose of rosuvastatin is 5 mg once daily, and if necessary, it can be maintained at 10 mg once daily, with a maximum dose of 20 mg per day, at any time of the day regardless of meals.

Child dose

Safety and efficacy in children under 18 years of age have not been established.

This medication can cause serious harm or death to the fetus and newborn when taken during the second and third trimesters of pregnancy; it must be discontinued immediately if pregnancy is confirmed. This medication is contraindicated in certain patients, such as those with allergies to this drug or its components, pregnant women or those who may become pregnant, nursing mothers, and patients with severe renal or hepatic impairment. Careful use is required in patients with depleted blood volume or sodium, patients with decreased renal function, and patients at risk for hyperkalemia, monitoring blood pressure, renal function, and serum potassium levels regularly during treatment. This medication may cause muscle-related side effects such as myalgia, myopathy, and, rarely, rhabdomyolysis, so inform healthcare professionals immediately if muscle pain or weakness occurs. Also, this medication may affect liver function, so it is important to undergo regular liver function tests before and during treatment. This medication can interact with other drugs; if you are taking other medications, be sure to inform your doctor or pharmacist, especially when taking potassium-sparing diuretics, lithium, or non-steroidal anti-inflammatory drugs. This medication should be used cautiously in patients who consume alcohol excessively or have a history of liver disease, and dosage adjustment may be necessary for the elderly or patients with specific genetic predispositions. Rarely, serious skin reactions or immune-mediated myopathies may occur, so discontinue use immediately and consult with healthcare professionals if skin rashes or severe muscle weakness occurs. This medication is not recommended for use in children and adolescents under 18 years of age, as safety and efficacy have not been established. In case of overdose, symptoms such as hypotension and palpitations may occur; immediate emergency treatment should be sought. This medication should be kept out of the reach of children, and transferring it to another container is not recommended as it may affect its quality.

Serious side effects

Urticaria, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, paleness, severe rash with fever, blisters, skin peeling, pain in oral/ocular mucosa, shortness of breath or difficulty breathing, asthma attacks, respiratory abnormalities accompanied by cough and fever, yellowing of the skin or eyes (jaundice), systemic malaise, sudden and severe headache, thunderclap headache, seizures, altered consciousness, vision abnormalities, paralysis, urination abnormalities

Mild side effects

• Headache
• dizziness
• sensory impairment
• drowsiness
• gastroesophageal reflux disease
• constipation
• dental caries
• dyspepsia
• gastric ulcer
• gastritis

This medication should be stored in a tightly closed container to protect it from light and air exposure. The recommended storage temperature is room temperature between 1 to 30 degrees Celsius.

Appearance

White or yellowish round film-coated tablets

Package unit

30 tablets/box [30 tablets ((10 tablets/Alu-Alu)x3)]